We fund groundbreaking research to learn more about muscle wasting conditions and lead us to new treatments. We’ve already made advances that would have been unthinkable just 10 years ago, and we are determined to go even further and faster.
Our research
We’ve already made advances that would have been unthinkable just 10 years ago, and we are determined to go even further and faster.
Transforming lives through research
Every day we’re working towards a future with effective treatments and ultimately cures for all muscle wasting and associated neuromuscular conditions. We believe this as passionately now as we did when we were established in 1959. It is this vision that unites us all and continues to drive our research strategy.
Our research projects
Browse our groundbreaking research to further our understanding of conditions, develop effective treatments, help people to live well and inform better care.
How we fund research
All of the projects we fund have gone through a vigorous peer review process. This ensures we’re funding the best quality science that’s relevant for people with muscle wasting conditions.
Our research achivements
We’ve been funding groundbreaking research for more than 60 years. Thanks to our incredible community, we’ve made advances that would have been unthinkable just a decade ago.
Together, we’re changing the future of muscle wasting conditions. Here are just a few examples how.
TAKE PART IN RESEARCH
Registries are databases that contain information about individuals affected by a particular condition. These are used to recruit eligible patients for clinical trials.
This is where we share opportunities for you to engage with research projects, surveys, and studies.
For researchers
Explore our open grant calls. Stay updated on pending decisions. Learn about our assessment panels and navigate our research policies. Advice on securing and managing grants. As well as post award information.
Research news
Accelerating the development of treatments for congenital muscular dystrophy – our £1 million partnership with LifeArc
April 14, 2025
New drug in development for primary mitochondrial myopathies
April 11, 2025
Researchers develop a new approach for muscle gene therapies
March 7, 2025
Stronger together
We are proud to be a member of a number of alliances. By working together we can be more efficient, save resources, and change the future of muscle wasting conditions faster.
